Cell & Gene Therapy Development & Production

Cell  and Gene Therapy products manufacturing focuses on various strategies like the manufacturing process must protect the product, patient, should focus on product characterization, process control, high throughput and parallel processing to achieve scale. The process/analytical development throughout clinical trials involve ongoing, iterative development of manufacturing process and characterization of profile and FDA expecting increasing control and characterization as clinical development progresses. Steps involved in individualized manufacturing and running in parallel for high throughput involves cell selection, expansion, activation, centrifugation and cryopreservation. 

  • Funding & Investment in the Cell & Gene Therapy field
  • Process Development and Scale-up for the product
  • Development Pathways for MSC Based Production
  • Cell counting and cell sorting technologies

Related Conference of Cell & Gene Therapy Development & Production

November 21-22, 2024

11th World Congress on Epigenetics and Chromosome

Dubai, UAE
December 09-10, 2024

17th World Congress on Stem Cell Research

Dubai, UAE
March 17-18, 2025

8th Global Conference on Cell and Gene Therapy

Paris, France
June 16-17, 2025

21st Global Summit on Stem Cell & Regenerative Medicine

Frankfurt, Germany

Cell & Gene Therapy Development & Production Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in